Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
World Journal of Gastrointestinal Pharmacology and Therapeutics|November 22, 2016
Family history and disease outcomes in patients with Crohn's disease: A comparison between China and the United StatesPei-Qi Wang, Jun Hu, Elie S Al Kazzi, et al.Gastroenterology Report|February 23, 2019
Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter studyXian-Rui Wu, Xiao-Bin Zheng, Yan Huang, et al.Gastroenterology Report|November 6, 2019
High-risk human papilloma virus infection and cervical neoplasm in female inflammatory bowel disease patients: a cross-sectional studyMiao Li, Qing-Fan Yang, Qian Cao, et al.Helicobacter|January 22, 2008
Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbilsGuo Qing Li, Harry H X Xia, Min Hu Chen, et al.World Journal of Gastroenterology|March 18, 2015
Corticosteroid therapy in ulcerative colitis: Clinical response and predictorsJin Li, Fan Wang, Hong-Jie Zhang, et al.Journal of Gastroenterology and Hepatology|July 17, 2020
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in AsiaZhihua Ran, Kaichun Wu, Katsuyoshi Matsuoka, et al.World Journal of Gastroenterology|April 5, 2013
Multicenter case-control study of the risk factors for ulcerative colitis in ChinaYu-Fang Wang, Qin Ou-Yang, Bing Xia, et al.The Journal of Infectious Diseases|March 7, 2006
Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammationGuo Qing Li, Harry Hua-Xiang Xia, Min Hu Chen, et al.Journal of Gastroenterology and Hepatology|October 13, 2017
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessmentDong Ii Park, Tadakazu Hisamatsu, Minhu Chen, et al.Journal of Gastroenterology and Hepatology|October 13, 2017
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: ManagementDong Il Park, Tadakazu Hisamatsu, Minhu Chen, et al.Pageof 8